Speaking of this March PDUFA, how much of an effect on the stock do you think this has with an approval?
We are in the teeth of a prospective bear market, where biotech has arguably been first down on any given session. I've never covered biotech in a down market, so I was curious what you guys thought as far as tempering expectations upon approval.
Thanks to all.